Koers Boston Therapeutics, Inc. Other OTC
Aandelen
BTHE
US1011501004
Geavanceerde medische apparatuur & technologie
Omzet 2021 | 142K 132K | Omzet 2022 | 15,45K 14,39K | Marktkapitalisatie | 9,32 mln. 8,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -8,38 mln. | Nettowinst (verlies) 2022 | -12 mln. -11,18 mln. | EV/omzet 2021 | 149 x |
Nettoschuld 2021 | 4,52 mln. 4,21 mln. | Nettoschuld 2022 | 11,39 mln. 10,61 mln. | EV/omzet 2022 | 1.340 x |
K/w-verhouding 2021 |
-1,75
x | K/w-verhouding 2022 |
-0,62
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 42,05% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 19-01-23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,45% | 8,82 mld. | |
+38,91% | 4,59 mld. | |
-30,31% | 2,64 mld. | |
-10,39% | 1,59 mld. | |
-21,90% | 1,35 mld. | |
-37,12% | 1,08 mld. | |
+2,95% | 921 mln. | |
-42,75% | 799 mln. | |
-23,56% | 677 mln. |